Pharmacyclics
Ibrutinib Bests Drug Combo in Older CLL Pts
In older patients with newly diagnosed chronic lymphocytic leukemia (CLL), ibrutinib provided a significant ...
MARCH 11, 2019
FDA Grants New Indication for Imbruvica for Marginal Zone Lymphoma
Prior to this indication, there were no FDA-approved therapies specifically for this disease.
JANUARY 19, 2017
Load more